Updated:
SYNAGEVA BIOPHARMA CORP
SYNAGEVA BIOPHARMA CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000911326, and its reported industry...
Overview
SYNAGEVA BIOPHARMA CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000911326, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2015-02-26, it reported annual revenue of USD 6,492,000; net income of USD -192,648,000; total assets of USD 504,203,000 for the fiscal period ended 2014-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- SYNAGEVA BIOPHARMA CORP
- Former names in filing history
- TRIMERIS INC (1997-10-01 to 2011-10-13)
- Classification
- Company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- Lexington, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0000911326
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2014USD | $6.5M | -$192.6M | $504.2M | $82.7M | — | |
| FY2013USD | $13.4M | -$95.5M | $447.9M | $62.1M | -$75.0M | |
| FY2012USD | $15.0M | -$42.9M | $243.3M | $23.9M | -$30.9M | |
| FY2011USD | $2.1M | -$25.3M | $83.3M | $60.2M | -$16.6M |
FY2011. Revenue, Net income, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | NOTICE & PROXY STATEMENT | ||
| 10-K | FORM 10-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research SYNAGEVA BIOPHARMA CORP in Altss
Track this company’s investors, transactions and relationships in Altss.